Assessment of Fetal Well-being in Second Trimester

Posted on by Soumya Ranjan Parida
Assessment of Fetal Well-being in Second Trimester: Comprehensive Guide

Assessment of Fetal Well-being in Second Trimester

A Comprehensive Guide for Nursing Students

Fetal Well-being Assessment

Table of Contents

1. Introduction to Fetal Well-being Assessment
2. Daily Fetal Movement Count (DFMC)
3. Biophysical Profile (BPP)
4. Non-Stress Test (NST)
5. Cardiotocography (CTG)
6. Ultrasound (USG) Assessment
7. Vibroacoustic Stimulation
8. Biochemical Tests
9. Best Practices & Updates
10. Clinical Applications

1. Introduction to Fetal Well-being Assessment

Fetal well-being assessment is a critical component of prenatal care, especially during the second trimester (14-28 weeks). These assessments aim to identify fetuses at risk for intrauterine distress, growth restriction, or death, enabling timely interventions to improve outcomes. The assessment techniques range from simple maternal perception of movements to sophisticated technological and biochemical evaluations.

Key Concept: Fetal well-being assessment involves both clinical examination and technological evaluation to ensure optimal fetal development and identify potential complications early.

In the second trimester, several physiological milestones make assessment particularly valuable:

  • Fetal movement becomes perceptible to the mother (quickening)
  • Fetal heart tones can be reliably detected
  • Anatomical structures are well-formed and assessable via ultrasound
  • Maternal-fetal circulation is well-established

2. Daily Fetal Movement Count (DFMC)

Daily Fetal Movement Count (DFMC) is one of the simplest, most cost-effective methods for assessing fetal well-being. It relies on maternal perception of fetal movements as an indicator of fetal health.

Technique

The DFMC technique involves:

  • Recording fetal movements perceived by the mother for one hour after meals (breakfast, lunch, and dinner)
  • Counting distinct movements (kicks, rolls, flutters)
  • Maintaining a daily chart of these movements
Nursing Tip: Instruct mothers to sit or lie in a left lateral position during counting to optimize circulation to the uterus and avoid false readings due to compression of the inferior vena cava.

Interpretation

Count Interpretation Action
≥3 movements per hour Satisfactory/Reassuring Continue routine monitoring
≥10 movements in 12 hours Normal Continue routine monitoring
<3 movements per hour Concerning/Non-reassuring Further assessment needed
Absence of movements Alarming Immediate medical evaluation
Clinical Alert: A significant reduction or cessation of fetal movements may indicate fetal compromise and requires immediate assessment. However, fetal sleep cycles normally last 20-40 minutes and should be considered when interpreting results.

3. Biophysical Profile (BPP)

The Biophysical Profile (BPP) is a comprehensive assessment of fetal well-being that evaluates five parameters, four by ultrasound and one by non-stress test. Though typically used in the third trimester, it may be initiated in the late second trimester in high-risk pregnancies.

Components of BPP

Parameter Normal Finding (2 points) Abnormal Finding (0 points)
Fetal Breathing Movements ≥1 episode of rhythmic breathing movements lasting ≥30 seconds in 30 minutes Absent or brief breathing movements
Gross Body Movements ≥3 discrete body/limb movements in 30 minutes <3 movements in 30 minutes
Fetal Tone ≥1 episode of extension with return to flexion of fetal limbs or trunk Slow extension with partial return or movement absence
Amniotic Fluid Volume ≥1 pocket of amniotic fluid measuring ≥2cm in perpendicular planes No or small pockets of amniotic fluid
Non-stress Test (NST) ≥2 accelerations of ≥15 beats/min lasting ≥15 seconds in 20 minutes 0 or 1 acceleration in 20 minutes

BPP Score Interpretation

Score Interpretation Management
8-10 Normal Routine follow-up
6 Equivocal Repeat test within 24 hours
4 Suspicious Further evaluation needed, consideration for delivery
0-2 Abnormal Immediate delivery if fetus viable
Modified BPP: This simplified version combines the NST with amniotic fluid assessment. It’s considered normal if both components are reassuring.

4. Non-Stress Test (NST)

The Non-Stress Test (NST) evaluates fetal heart rate (FHR) response to fetal movement, reflecting the integrity of the fetal autonomic nervous system and cardiac function. It can be performed as early as 24-26 weeks gestation in the second trimester.

Procedure

  1. Position patient in semi-Fowler’s or left lateral position
  2. Apply external electronic fetal monitor with tocodynamometer
  3. Observe and record FHR for 20-30 minutes
  4. Ask mother to press event marker button when fetal movement is felt
  5. Document contractions, baseline FHR, variability, accelerations, and decelerations

Interpretation

Result Criteria Interpretation
Reactive (Normal) ≥2 FHR accelerations of ≥15 beats/min lasting ≥15 seconds in 20 minutes Reassuring fetal status
Non-reactive Insufficient accelerations as defined above May indicate fetal compromise or sleep cycle
Unsatisfactory Poor quality tracing, insufficient monitoring time Repeat test
Nursing Tip: If the NST is non-reactive, extend the monitoring time to 40 minutes to account for fetal sleep cycles. Offering the mother a small snack or cold water can stimulate fetal activity.

5. Cardiotocography (CTG)

Cardiotocography (CTG) is a technical method of recording the fetal heartbeat and uterine contractions simultaneously. Though more commonly used in the third trimester, it can be valuable in the late second trimester (after 24 weeks) when concerning symptoms arise.

Technical Aspects

CTG uses two transducers placed on the mother’s abdomen:

  • Ultrasound transducer: Records fetal heart rate using Doppler ultrasound principles
  • Pressure transducer: Records uterine contractions (tocodynamometer)

Parameters Assessed

Parameter Normal Range Abnormal Findings
Baseline FHR 110-160 bpm Bradycardia (<110 bpm) or Tachycardia (>160 bpm)
Variability 5-25 bpm Reduced (<5 bpm) or Absent (0 bpm)
Accelerations Present with fetal movement Absent
Decelerations Absent Early, Late, or Variable decelerations
Contractions 0-5 in 10 minutes >5 in 10 minutes (tachysystole)
Second Trimester Considerations: CTG interpretation in the second trimester should be done cautiously, as baseline variability may not be fully developed until 28 weeks. Assessments should be made by experienced practitioners and considered alongside other clinical findings.

6. Ultrasound (USG) Assessment

Ultrasound is a cornerstone in the assessment of fetal well-being during the second trimester. It provides detailed information about fetal anatomy, growth, and development without ionizing radiation.

Key Parameters Assessed

  • Fetal growth parameters:
    • Biparietal diameter (BPD)
    • Head circumference (HC)
    • Abdominal circumference (AC)
    • Femur length (FL)
    • Estimated fetal weight (EFW)
  • Amniotic fluid assessment:
    • Single deepest pocket (SDP)
    • Amniotic fluid index (AFI)
  • Placental assessment:
    • Location and morphology
    • Placental grade
  • Doppler ultrasound:
    • Umbilical artery blood flow
    • Middle cerebral artery blood flow
    • Ductus venosus flow (in high-risk cases)

Amniotic Fluid Assessment Norms

Parameter Normal Range Clinical Significance
Amniotic Fluid Index (AFI) 8-24 cm <8 cm: Oligohydramnios
>24 cm: Polyhydramnios
Single Deepest Pocket (SDP) 2-8 cm <2 cm: Oligohydramnios
>8 cm: Polyhydramnios
Clinical Application: Abnormal amniotic fluid volumes can indicate fetal anomalies, placental insufficiency, or maternal conditions requiring further assessment. Oligohydramnios may suggest renal anomalies or placental insufficiency, while polyhydramnios may indicate maternal diabetes, fetal anomalies, or infections.

7. Vibroacoustic Stimulation

Vibroacoustic stimulation (VAS) is a simple, non-invasive technique to assess fetal response to external stimuli, particularly useful when combined with NST to improve test efficiency.

Procedure

  1. Place an electronic artificial larynx (vibroacoustic stimulator) on the maternal abdomen over the fetal head
  2. Activate the device to produce a sound stimulus (usually 80-90 dB) for 1-2 seconds
  3. Observe the fetal heart rate response
  4. The stimulation may be repeated up to 3 times if no response is obtained

Interpretation

Response Interpretation
FHR acceleration within 10 seconds Reassuring (normal response)
No FHR acceleration after 3 stimulations Non-reassuring (may indicate fetal compromise)
Caution: VAS should be used judiciously. Some studies suggest it may cause excessive fetal movements, prolonged tachycardia, and disruption in behavioral states. It should not be used routinely but reserved for specific clinical situations.

Clinical Applications

  • Shortening the duration of non-stress tests
  • Stimulating fetal movement during biophysical profile assessment
  • Differentiating between fetal sleep and compromise in non-reactive NSTs

8. Biochemical Tests

Biochemical markers provide valuable insights into fetal well-being and development during the second trimester. These tests can help identify potential chromosomal abnormalities, neural tube defects, and other conditions that may affect fetal health.

Second Trimester Biochemical Markers

Marker Clinical Significance Normal Range (MoM*)
Alpha-Fetoprotein (AFP) Elevated: Neural tube defects, abdominal wall defects
Decreased: Down syndrome		 0.5-2.5
Unconjugated Estriol (uE3) Decreased: Down syndrome, trisomy 18, IUGR 0.5-2.0
Human Chorionic Gonadotropin (hCG) Elevated: Down syndrome
Decreased: Trisomy 18		 0.5-2.0
Inhibin A Elevated: Down syndrome 0.5-2.0

*MoM = Multiple of the Median

Screening Test Combinations

  • Triple Test: AFP + uE3 + hCG
    • Detection rate for Down syndrome: 60-70%
  • Quadruple (Quad) Test: AFP + uE3 + hCG + Inhibin A
    • Detection rate for Down syndrome: 75-80%
    • Optimal timing: 15-22 weeks (ideally 16-18 weeks)
Integrated Approach: When second-trimester biochemical tests are combined with first-trimester screening (NT, PAPP-A, free β-hCG), the detection rate for Down syndrome can exceed 90% with a false positive rate of around 5%.

Emerging Biochemical Markers

  • Cell-free fetal DNA in maternal blood: Non-invasive prenatal testing with high sensitivity and specificity for common aneuploidies
  • Placental Growth Factor (PlGF): Decreased levels may indicate risk for preeclampsia or fetal growth restriction
  • Pregnancy-Associated Plasma Protein-A (PAPP-A): Low second-trimester levels may indicate risk for adverse pregnancy outcomes

9. Best Practices & Updates

Recent advancements and best practices in fetal well-being assessment have improved outcomes and patient experience. Here are three key updates that nursing professionals should be aware of:

1. Integration of Multiple Assessment Modalities

Current best practice emphasizes using multiple complementary assessment techniques rather than relying on a single method. This integrated approach provides more accurate evaluation of fetal status and reduces false positive/negative results.

Example: Combining maternal DFMC monitoring with periodic biophysical assessments has shown greater sensitivity in detecting early signs of fetal compromise compared to either technique alone.

2. Personalized Assessment Schedules

Recent guidelines recommend tailoring the frequency and type of fetal assessments based on individual risk profiles rather than applying a one-size-fits-all approach.

High-risk pregnancies (e.g., maternal hypertension, diabetes, previous stillbirth) may require BPP assessments beginning as early as 26-28 weeks, while low-risk pregnancies may focus primarily on maternal perception of movement with clinical validation.

3. Technological Advancements in Monitoring

New developments in fetal monitoring technology have enhanced our ability to assess fetal well-being with greater precision and convenience.

Remote monitoring solutions now allow pregnant women to record fetal movements and heart rates at home using smartphone-connected devices, with data transmitted directly to healthcare providers for review. This has shown particular benefit during the COVID-19 pandemic by reducing in-person visits while maintaining surveillance.

Evidence-Based Practice: A 2023 meta-analysis showed that implementing a structured fetal movement education program combined with standardized response protocols reduced stillbirth rates by 28% compared to standard care.

10. Clinical Applications

As nursing professionals, understanding when and how to apply different fetal well-being assessment techniques is crucial for optimal patient care.

Indications for Fetal Well-being Assessment in the Second Trimester

Maternal Factors Fetal Factors Pregnancy Factors
  • Hypertensive disorders
  • Diabetes mellitus
  • Autoimmune diseases
  • Advanced maternal age (≥35 years)
  • Substance abuse
  • Suspected IUGR
  • Abnormal findings on screening tests
  • Decreased fetal movement
  • Multiple gestation
  • Congenital anomalies
  • Previous stillbirth
  • Placental abnormalities
  • Polyhydramnios/Oligohydramnios
  • Antepartum hemorrhage
  • Post-term pregnancy

Nursing Role in Fetal Well-being Assessment

  1. Patient Education: Teaching pregnant women how to monitor fetal movements and when to seek medical attention
  2. Procedure Assistance: Preparing equipment, positioning patients, and assisting during ultrasound, NST, and BPP
  3. Monitoring: Recognizing normal and abnormal patterns during electronic fetal monitoring
  4. Documentation: Accurately recording all findings and communicating results to the healthcare team
  5. Support: Providing emotional support to patients, particularly when abnormal findings generate anxiety

Decision-Making Algorithm for Decreased Fetal Movement

  1. Perform focused history and assessment
  2. Initiate electronic fetal monitoring (NST)
  3. If non-reactive NST, proceed to BPP
  4. Normal BPP (≥8/10): Continue routine prenatal care with increased surveillance
  5. Abnormal BPP (≤6/10): Consider further testing and possible delivery planning based on gestational age and clinical context

Focus Keyword: Fetal Well-being Assessment

These notes are designed for educational purposes for nursing students. Clinical decisions should always be made in accordance with current guidelines and under appropriate supervision.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts